参考文献

［1］ MORRIS P J. Transplantation--a medical miracle of the 20th century [J]. N Engl J Med, 2004, 351 (26):2678-2680.

［2］ BLACK C K, TERMANINI K M, AGUIRRE O, et al. Solid organ transplantation in the 21 (st) century [J].Ann Transl Med, 2018, 6 (20): 409.

［3］ ELTZSCHIG H K, ECKLE T. Ischemia and reperfusion--from mechanism to translation [J]. Nat Med, 2011,17 (11): 1391-1401.

［4］ JASSEM W, XYSTRAKIS E, GHNEWA Y G, et al. Normothermic machine perfusion (NMP) inhibits proinflammatory responses in the liver and promotes regeneration [J]. Hepatology, 2019, 70 (2): 682-695.

［5］ JAESCHKE H, WOOLBRIGHT B L. Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species [J]. Transplant Rev (Orlando), 2012, 26 (2): 103-114.

［6］ ZUIDEMA M Y, ZHANG C. Ischemia/reperfusion injury: the role of immune cells [J]. World J Cardiol,2010, 2 (10): 325-332.

［7］ VAN BEEKUM C J, VILZ T O, GLOWKA T R, et al. Normothermic machine perfusion (NMP) of the livercurrent status and future perspectives [J]. Ann Transplant, 2021, 26: e931664.

［8］ TATUM R, O′MALLEY T J, BODZIN A S, et al. Machine perfusion of donor organs for transplantation [J].Artif Organs, 2021, 45 (7): 682-695.

［9］ LEMBACH JAHNSEN H, MERGENTAL H, PERERA M, et al. Ex-situ liver preservation with machine preservation [J]. Curr Opin Organ Transplant, 2021, 26 (2): 121-132.

［10］ BARROU B, BILLAULT C, NICOLAS-ROBIN A. The use of extracorporeal membranous oxygenation in donors after cardiac death [J]. Curr Opin Organ Transplant, 2013, 18 (2): 148-153.

［11］ BUTLER A J, RANDLE L V, WATSON C J. Normothermic regional perfusion for donation after circulatory death without prior heparinization [J]. Transplantation, 2014, 97 (12): 1272-1278.

［12］ DE ROUGEMONT O, LEHMANN K, CLAVIEN P A. Preconditioning, organ preservation, and postconditioning to prevent ischemia-reperfusion injury to the liver [J]. Liver Transpl, 2009, 15 (10): 1172-1182.

［13］ GUO Z Y, FUNG U E, TANG Y H, et al. The era of“warm organ transplantation”is coming [J]. Am J Transplant, 2018, 18 (8): 2092-2093.

［14］ MOERS C, PIRENNE J, PAUL A, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation [J]. N Engl J Med, 2012, 366 (8): 770-771.

［15］ CERESA C D L, NASRALLA D, KNIGHT S, et al. Cold storage or normothermic perfusion for liver transplantation: probable application and indications [J]. Curr Opin Organ Transplant, 2017, 22 (3):300-305.

［16］ VAN RIJN R, SCHURINK I J, DE VRIES Y, et al. Hypothermic machine perfusion in liver transplantation-a randomized trial [J]. N Engl J Med, 2021, 384 (15): 1391-1401.

［17］ NASRALLA D, COUSSIOS C C, MERGENTAL H, et al. A randomized trial of normothermic preservation in liver transplantation [J]. Nature, 2018, 557 (7703): 50-56.

［18］ JAYANT K, RECCIA I, SHAPIRO A M J. Normothermic ex-vivo liver perfusion: where do we stand and where to reach？[J]. Expert Rev Gastroenterol Hepatol, 2018, 12 (10): 1045-1058.

［19］ HESSHEIMER A J, RIQUELME F, FUNDORA-SUáREZ Y, et al. Normothermic perfusion and outcomes after liver transplantation [J]. Transplant Rev (Orlando), 2019, 33 (4): 200-208.

［20］ PEZZATI D, LIU Q, HASSAN A, et al. Normothermic machine perfusion: a new world deserving careful exploration [J]. Am J Transplant, 2017, 17 (7): 1956-1957.

［21］ SIERRA PARRAGA J M, ROZENBERG K, EIJKEN M, et al. Effects of normothermic machine perfusion conditions on mesenchymal stromal cells [J]. Front Immunol, 2019, 10: 765.

［22］ LOHMANN S, POOL M B F, ROZENBERG K M, et al. Mesenchymal stromal cell treatment of donor kidneys during ex vivo normothermic machine perfusion: a porcine renal autotransplantation study [J]. Am J Transplant, 2021, 21 (7): 2348-2359.

［23］ XU J, BUCHWALD J E, MARTINS P N. Review of current machine perfusion therapeutics for organ preservation [J]. Transplantation, 2020, 104 (9): 1792-1803.

［24］ WEISSENBACHER A, VRAKAS G, NASRALLA D, et al. The future of organ perfusion and re-conditioning [J]. Transpl Int, 2019, 32 (6): 586-597.

［25］ VON HORN C, MINOR T. Modern concepts for the dynamic preservation of the liver and kidneys in the context of transplantation [J]. Pathologe, 2019, 40 (3): 292-298.

［26］ CYPEL M, YEUNG J C, LIU M Y, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation [J]. N Engl J Med, 2011, 364 (15): 1431-1340.

［27］ DHITAL K K, IYER A, CONNELLAN M, et al. Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series [J]. Lancet, 2015, 385 (9987):2585-2591.

［28］ HE X S, GUO Z Y, ZHAO Q, et al. The first case of ischemia-free organ transplantation in humans: a proof of concept [J]. Am J Transplant, 2018, 18 (3): 737-744.

［29］ GUO Z Y, ZHAO Q, HUANG S Z, et al. Ischaemia-free liver transplantation in humans: a first-in-human trial [J]. Lancet Reg Health West Pac, 2021, 16: 100260.

［30］ VAN LEEUWEN O B, UBBINK R, DE MEIJER V E, et al. The first case of ischemia-free organ transplantation in humans: a proof of concept [J]. Am J Transplant, 2018, 18 (8): 2091.

［31］ HE X S, CHEN G D, ZHU Z B, et al. The first case of ischemia-free kidney 00000transplantation in humans [J]. Front Med (Lausanne), 2019, 6: 276.

［32］ ZHAO Q, NIE Y, GUO Z Y, et al. The future of organ-oriented research and treatment [J]. Hepatobiliary Surg Nutr, 2019, 8 (5): 502-505.